International Diabetes Federation. IDF Diabetes Atlas, 10th edn, 2021.

World Health O. Classification of diabetes mellitus. Geneva: World Health Organization; 2019 2019.

Zheng Y, Ley S, Hu F. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications[J]. Nat Reviews Endocrinol. 2018;14(2):88–98.

Google Scholar 

Sakuraba H, Mizukami H, Yagihashi N, Wada R, Hanyu C, Yagihashi S. Reduced beta-cell mass and expression of oxidative stress-related DNA damage in the islet of Japanese type II diabetic patients[J]. Diabetologia. 2002;45(1):85–96.

CAS  PubMed  Google Scholar 

Lin J, Hsia T, Wu C, Su C, Ma W, Hsieh A, et al. The first and second phase of insulin secretion in naive Chinese type 2 diabetes mellitus[J]. Metab Clin Exp. 2010;59(6):780–6.

CAS  PubMed  Google Scholar 

Di Giuseppe G, Ciccarelli G, Soldovieri L, Capece U, Cefalo C, Moffa S, et al. First-phase insulin secretion: can its evaluation direct therapeutic approaches?[J]. Trends Endocrinol Metab. 2023;34(4):216–30.

PubMed  Google Scholar 

Del Prato S, Tiengo A. The importance of first-phase insulin secretion: implications for the therapy of type 2 diabetes mellitus[J]. Diab/Metab Res Rev. 2001;17(3):164–74.

Google Scholar 

Maedler K, Donath M. Beta-cells in type 2 diabetes: a loss of function and mass. Horm Res. 2004;67:67–73.

Inaishi J, Saisho Y. Beta-cell mass in obesity and type 2 diabetes, and its relation to pancreas fat: a mini-review[J]. Nutrients. 2020;12(12).

Yoon K, Lee J, Kim J, Cho J, Choi Y, Ko S, et al. Epidemic obesity and type 2 diabetes in Asia[J]. Lancet (London England). 2006;368(9548):1681–8.

PubMed  Google Scholar 

Li Y, Teng D, Shi X, Qin G, Qin Y, Quan H et al. Prevalence of diabetes recorded in mainland China using 2018 diagnostic criteria from the American Diabetes Association: national cross sectional study. BMJ. 2020;369.

Zhong X. Diabetes mellitus survey in China[J]. Chin Med J. 1982;95(6):423–30.

CAS  PubMed  Google Scholar 

Yang L, Shao J, Bian Y, Wu H, Shi L, Zeng L, et al. Prevalence of type 2 diabetes mellitus among inland residents in China (2000–2014): a meta-analysis[J]. J Diabetes Invest. 2016;7(6):845–52.

Google Scholar 

Yan J, Peng D, Jiang F, Zhang R, Chen M, Wang T, et al. Impaired pancreatic beta cell compensatory function is the main cause of type 2 diabetes in individuals with high genetic risk: a 9 year prospective cohort study in the Chinese population[J]. Diabetologia. 2016;59(7):1458–62.

CAS  PubMed  Google Scholar 

Li S, Cui Y, Luo Z, Lou Y, Liao M, Chen H, et al. Association between blood urea nitrogen and incidence of type 2 diabetes mellitus in a Chinese population: a cohort study[J]. Endocr J. 2021;68(9):1057–65.

CAS  PubMed  Google Scholar 

Quan JLT, Pang H, Choi CH, Siu SC, Tang SY, Wat NMS, Woo J, Johnston JM, Leung GM. Diabetes incidence and prevalence in Hong Kong, China during 2006–2014[J]. Diabet Med. 2017;34(7):902–8.

CAS  PubMed  Google Scholar 

Lin C, Li C, Hsiao C, Liu C, Yang S, Lee C, et al. Time trend analysis of the prevalence and incidence of diagnosed type 2 diabetes among adults in Taiwan from 2000 to 2007: a population-based study[J]. BMC Public Health. 2013;13:318.

PubMed  PubMed Central  Google Scholar 

Seino S, Shibasaki T, Minami K. Dynamics of insulin secretion and the clinical implications for obesity and diabetes[J]. J Clin Invest. 2011;121(6):2118–25.

CAS  PubMed  PubMed Central  Google Scholar 

Pang C, Bao YQ, Wang C, Lu JX, Jia WP, Xiang KS. Relationship between the level of fasting plasma glucose and beta cell functions in Chinese with or without diabetes[J]. Chin Med J (Engl). 2008;121(21):2119–23.

CAS  PubMed  Google Scholar 

Choi C, Kim M, Han K, Lee M. Assessment of β-cell function in human patients[J]. Islets. 2012;4(2):79–83.

PubMed  Google Scholar 

Inaishi J, Saisho Y. Ethnic similarities and differences in the relationship between beta cell mass and diabetes. J Clin Med. 2017;6(12).

Saisho Y. Postprandial C-peptide to glucose ratio as a marker of β cell function: implication for the management of type 2 diabetes[J]. Int J Mol Sci. 2016;17(5).

Torréns J, Skurnick J, Davidow A, Korenman S, Santoro N, Soto-Greene M, et al. Ethnic differences in insulin sensitivity and beta-cell function in premenopausal or early perimenopausal women without diabetes: the study of women’s Health across the Nation (SWAN)[J]. Diabetes Care. 2004;27(2):354–61.

PubMed  Google Scholar 

Kodama K, Tojjar D, Yamada S, Toda K, Patel C, Butte A. Ethnic differences in the relationship between insulin sensitivity and insulin response: a systematic review and meta-analysis[J]. Diabetes Care. 2013;36(6):1789–96.

CAS  PubMed  PubMed Central  Google Scholar 

Møller J, Pedersen M, Tanaka H, Ohsugi M, Overgaard R, Lynge J, et al. Body composition is the main determinant for the difference in type 2 diabetes pathophysiology between Japanese and Caucasians[J]. Diabetes Care. 2014;37(3):796–804.

PubMed  Google Scholar 

Ahuja V, Kadowaki T, Evans R, Kadota A, Okamura T, El Khoudary S, et al. Comparison of HOMA-IR, HOMA-β% and disposition index between US white men and Japanese men in Japan: the ERA JUMP study[J]. Diabetologia. 2015;58(2):265–71.

PubMed  Google Scholar 

Møller J, Dalla Man C, Overgaard R, Ingwersen S, Tornøe C, Pedersen M, et al. Ethnic differences in insulin sensitivity, β-cell function, and hepatic extraction between Japanese and caucasians: a minimal model analysis[J]. J Clin Endocrinol Metab. 2014;99(11):4273–80.

PubMed  Google Scholar 

Li L, Zou X, Huang Q, Han X, Zhou X, Ji L. Do East Asians with normal glucose tolerance have worse β-cell function? A meta-analysis of epidemiological studies. Front Endocrinol. 2021;12:780557.

Ma RCW. Epidemiology of diabetes and diabetic complications in China[J]. Diabetologia. 2018;61(6):1249–60.

PubMed  Google Scholar 

Daousi C, Casson IF, Gill GV, MacFarlane IA, Wilding JP, Pinkney JH. Prevalence of obesity in type 2 diabetes in secondary care: association with cardiovascular risk factors[J]. Postgrad Med J. 2006;82(966):280–4.

CAS  PubMed  PubMed Central  Google Scholar 

Gao Z, Yan W, Fang Z, Zhang Z, Yuan L, Wang X, et al. Annual decline in β-cell function in patients with type 2 diabetes in China[J]. Diab/Metab Res Rev. 2021;37(2):e3364.

CAS  Google Scholar 

U.K. prospective diabetes study 16. Overview of 6 years’ therapy of type II diabetes: a progressive disease. U.K. prospective diabetes Study Group[J]. Diabetes. 1995;44(11):1249–58.

Google Scholar 

Yoon K, Ko S, Cho J, Lee J, Ahn Y, Song K, et al. Selective beta-cell loss and alpha-cell expansion in patients with type 2 diabetes mellitus in Korea[J]. J Clin Endocrinol Metab. 2003;88(5):2300–8.

CAS  PubMed  Google Scholar 

Hsia D, Larrivee S, Cefalu W, Johnson W. Impact of lowering BMI cut points as recommended in the Revised American Diabetes Association’s standards of Medical Care in Diabetes-2015 on diabetes screening in Asian Americans[J]. Diabetes Care. 2015;38(11):2166–8.

PubMed  PubMed Central  Google Scholar 

Matveyenko A, Butler P. Relationship between beta-cell mass and diabetes onset. Diabetes Obes Metab. 2008;10:23-31.

Campbell JE, Newgard CB. Mechanisms controlling pancreatic islet cell function in insulin secretion[J]. Nat Rev Mol Cell Biol. 2021;22(2):142–58.

CAS  PubMed  PubMed Central  Google Scholar 

Hudish LI, Reusch JE, Sussel L. β cell dysfunction during progression of metabolic syndrome to type 2 diabetes[J]. J Clin Invest. 2019;129(10):4001–8.

PubMed  PubMed Central  Google Scholar 

Fu Z, Gilbert ER, Liu D. Regulation of insulin synthesis and secretion and pancreatic Beta-cell dysfunction in diabetes[J]. Curr Diabetes Rev. 2013;9(1):25–53.

PubMed  PubMed Central  Google Scholar 

Sander M, Neubüser A, Kalamaras J, Ee HC, Martin GR, German MS. Genetic analysis reveals that PAX6 is required for normal transcription of pancreatic hormone genes and islet development[J]. Genes Dev. 1997;11(13):1662–73.

CAS  PubMed  Google Scholar 

Zhao L, Guo M, Matsuoka TA, Hagman DK, Parazzoli SD, Poitout V, et al. The islet beta cell-enriched MafA activator is a key regulator of insulin gene transcription[J]. J Biol Chem. 2005;280(12):11887–94.

CAS  PubMed  Google Scholar 

Lomedico PT, Chan SJ, Steiner DF, Saunders GF. Immunological and chemical characterization of bovine preproinsulin[J]. J Biol Chem. 1977;252(22):7971–8.

CAS  PubMed  Google Scholar 

Patzelt C, Labrecque AD, Duguid JR, Carroll RJ, Keim PS, Heinrikson RL, et al. Detection and kinetic behavior of preproinsulin in pancreatic islets[J]. Proc Natl Acad Sci U S A. 1978;75(3):1260–4.

CAS  PubMed  PubMed Central  Google Scholar 

Huang XF, Arvan P. Intracellular transport of proinsulin in pancreatic beta-cells. Structural maturation probed by disulfide accessibility[J]. J Biol Chem. 1995;270(35):20417–23.

CAS  PubMed  Google Scholar 

Fang J, Liu M, Zhang X, Sakamoto T, Taatjes DJ, Jena BP, et al. COPII-Dependent ER export: a critical component of insulin Biogenesis and β-Cell ER Homeostasis[J]. Mol Endocrinol. 2015;29(8):1156–69.

CAS  PubMed  PubMed Central  Google Scholar 

Vakilian M, Tahamtani Y, Ghaedi K. A review on insulin trafficking and exocytosis[J]. Gene. 2019;706:52–61.

CAS  PubMed  Google Scholar 

Jiang Q, Zhao Q, Chen Y, Ma C, Peng X, Wu X, et al. Galectin-3 impairs calcium transients and β-cell function[J]. Nat Commun. 2024;15(1):3682.

CAS  PubMed  PubMed Central